Analysen von James Gordon
| 14.06.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.06.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 30.05.23 | MorphoSys Underweight | JP Morgan Chase & Co. | |
| 17.05.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 16.05.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.05.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.05.23 | MorphoSys Underweight | JP Morgan Chase & Co. | |
| 04.05.23 | GSK Underweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 02.05.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 27.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 27.04.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 27.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 18.04.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 11.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.04.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.04.23 | MorphoSys Underweight | JP Morgan Chase & Co. | |
| 24.03.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 17.03.23 | MorphoSys Underweight | JP Morgan Chase & Co. | |
| 16.03.23 | MorphoSys Underweight | JP Morgan Chase & Co. | |
| 10.03.23 | MorphoSys Underweight | JP Morgan Chase & Co. | |
| 09.03.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.03.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.03.23 | MorphoSys Underweight | JP Morgan Chase & Co. | |
| 02.03.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 09.02.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.02.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.02.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.02.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 31.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 19.01.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 12.01.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 11.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.12.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.12.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 18.11.22 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 17.11.22 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 14.11.22 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 10.11.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.11.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 28.10.22 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 27.10.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 27.10.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 26.10.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.10.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 21.10.22 | MorphoSys Neutral | JP Morgan Chase & Co. | |